Toronto Dominion Bank’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
VCM
VPM
Toronto Dominion Bank's MRNA Position: Q1 2026 in Review
Toronto Dominion Bank reduced its Moderna (MRNA) stake by 20% in Q1 2026, selling an estimated $735K and leaving 62,012 shares worth $3.15M. The position accounts for ﹤0.01% of the portfolio, ranked #999.
Toronto Dominion Bank first reported a position in MRNA in Q2 2020 and has held it in 24 quarters since. The position peaked at $120M in Q3 2021. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.
- Toronto Dominion Bank held 62,012 shares of Moderna worth $3.15M as of Q1 2026.
- Toronto Dominion Bank sold 15,760 Moderna shares in Q1 2026, an estimated $735K.
- Moderna made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #999 holding.
- Toronto Dominion Bank first reported a position in Moderna in Q2 2020 and has held it in 24 quarters since.
- Toronto Dominion Bank's Moderna position peaked at $120M in Q3 2021.
- 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.
Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.